# CIRCULATE-US (NCT05174169)

> Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05174169
- Phase: PHASE2, PHASE3
- Status: RECRUITING
- Sponsor: NRG Oncology
- Conditions: Stage III Colon Cancer
- Interventions: Signatera test; mFOLFOX6 3-6 month; CAPOX 3 month; mFOLFIRINOX; mFOLFOX6 6 month; CAPOX 6 month
- Enrollment: 1912
- Primary outcome: ctDNA positive status (TTPos)
- Primary outcome: Disease-Free Survival (DFS)

## Commentary we found

- YouTube: 46
- X threads: 41
- Podcasts: 29

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=circulate-us-nct05174169

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05174169", "email": "<work email>"}; the inbox owner confirms by the emailed link.